Syndax Pharmaceuticals, Inc. ($SNDX)
Goldan Keith A. โ Chief Financial Officer
Shares
21,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Goldan Keith A. |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 4, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 4, 2026 |
| Shares Purchased | 21,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 115,171 |
| Derivative | No |
| Accession Number | 0001193125-26-041497 |
| Document | View SEC Filing |